8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Feb 26, 2025.
The trade is 8.1% of the 307,236 shares held after it.
2 other insiders sold within 30 days.
Insider activity: President and CEO Steigerwalt Eric T sold about $1.5M of BHF on May 27, 2025, the largest insider sale at the company on our record; 2 other insiders sold within 30 days.
Nobody has filed for crossing 5%. That is a fact, not missing data.
BHF planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Steigerwalt
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$10.5M
$13.5M
$3.3M
+79%
+101%
2024
$10.1M
$8.0M
$3.1M
+22%
+72%
2023
$10.0M
$11.4M
$3.2M
+35%
+43%
2022
$9.8M
$6.7M
$3.2M
+31%
+37%
2021
$7.9M
$12.6M
$2.9M
+32%
+24%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt BHF
FY Dec 2025
0.08x
FY Dec 2024
-0.09x
FY Dec 2023
-0.04x
FY Dec 2022
-0.39x
FY Dec 2021
0.20x
Jun 2026
-0.17x
Mar 2026
-0.03x
Dec 2025
0.08x
Sep 2025
0.05x
Jun 2025
0.02x
Mar 2025
0.12x
Dec 2024
-0.09x
Sep 2024
-0.01x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+11.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity BHF
FY Dec 2025
+5.6%
FY Dec 2024
+5.8%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
+9.1%
Jun 2026
+11.9%
Mar 2026
-3.1%
Dec 2025
+5.6%
Sep 2025
+14.6%
Jun 2025
+11.5%
Mar 2025
+10.8%
Dec 2024
+5.8%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets BHF
FY Dec 2025
+0.1%
FY Dec 2024
+0.1%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
+0.6%
Jun 2026
+0.3%
Mar 2026
-0.1%
Dec 2025
+0.1%
Sep 2025
+0.4%
Jun 2025
+0.2%
Mar 2025
+0.2%
Dec 2024
+0.1%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital BHF
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed BHF
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
3.57x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing BHF
FY Dec 2025
11.17x
FY Dec 2024
9.95x
FY Dec 2023
n/a
FY Dec 2022
1.03x
FY Dec 2021
2.77x
Jun 2026
5.05x
Mar 2026
n/a
Dec 2025
11.17x
Sep 2025
3.70x
Jun 2025
6.03x
Mar 2025
7.24x
Dec 2024
9.95x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$933.5M
market value at close 2026-10-27 on 2026-07-31 shares, plus long-term debt only, 2026-06-30, minus cash 2022-09-30
Enterprise value BHF
FY Dec 2025
$2.1B
FY Dec 2024
$1.2B
FY Dec 2023
$1.8B
FY Dec 2022
$1.9B
FY Dec 2021
$2.8B
Jun 2026
$2.0B
Mar 2026
$1.8B
Dec 2025
$2.1B
Sep 2025
$1.4B
Jun 2025
$1.4B
Mar 2025
$1.7B
Dec 2024
$1.2B
Sep 2024
$1.1B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield BHF
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.09x
P/E over trailing EPS growth of 41%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing BHF
FY Dec 2025
0.56x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.01x
FY Dec 2021
n/a
Jun 2026
0.12x
Mar 2026
n/a
Dec 2025
0.56x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BHF ranks highest on growth (88th percentile) and risk and compliance (34th), and lowest on institutional and government (6th), among Insurance peers.
Profitability
30
Inputs
Return on equity+11.9% · 40 pct, sector of 116
Return on assets+0.3% · 20 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
19
Inputs
Debt to equity0.48x · 27 pct, sector of 104
Cash flow to debt-0.17x · 10 pct, sector of 97
Growth
88
Inputs
Revenue growth, YoY+43.2% · 88 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
6
Inputs
Funds adding, latest quarterfewer than five funds report holding it
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$60K · 6 pct, sector of 35
Risk and compliance
34
Inputs
Short interest, % of float+12.1% · 6 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+8.6% · 61 pct, sector of 110
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.